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Patient and Public Involvement/Engagement (PPI/E) in public health research and Health 
Technology Assessment (HTA) in High-Income Countries (HIC) has significantly increased 
over past decade. PPI/E helps improve research and HTA ultimately benefitting patients and 
service users.  
PPI/E is very new concept in many LMICs (Low- and Middle-Income Countries). This paper 
considers the importance of PPI in public health research and HTA in the development and 
implementation of technology in the health sector in South Asia. Currently, in this region, 
health technology is frequently adopted from HICs without local research and HTA. It also 
discusses the importance of local co-creation of technology to reflect the needs of users 
within a culturally appropriate setting. It is important for LMIC-based researchers to 
understand the potential of PPI/E and how it can contribute to it to improve health care and 
research, especially perhaps in the era of COVID-19.  
 
Background  
Patient and Public Involvement/Engagement (PPI/E) is vital in research and Health 
Technology Assessment (HTA) supporting a patient/person-centred care approach. There is a 
growing interest in implementing PPI/E in health research in LMIC ((Low- and Middle-
Income Countries). because it benefits the: (a) research question; (b) conduct of the research; 
and (c) beneficiaries. (Cook et al., 2019; Puerta, Bartlam and Smith, 2019). The UK 
organisation INVOLVE (NIHR/INVOLVE, 2019) defines public involvement  as “research 
being carried out 'with' or 'by' members of the public rather than 'to', 'about' or 'for' them”.  
Public can refer to patients, potential patients, carers and people from organizations that 
represent service users as well as members of the public.  Thus PPI ‘occurs when individuals 
meaningfully and actively collaborate in the governance, priority setting, and conduct of 
research, as well as in summarizing, distributing, sharing, and applying its resulting 
knowledge’ (IHRF, 2015).  
HTA is a systematic approach to evaluate the properties, effects, and impacts of health 
technologies or interventions (WHO, 2015), to inform policy and clinical decision making in 
the application of health technologies. HTA involves interdisciplinary research to assess cost 
effectiveness, budget impact, programmatic feasibility and social and ethical issues of health 
interventions (Hailey et al., 2010). Health technology is critical elements in Universal Health 
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Coverage (UHC) (WHO, 2019) and HTA is recognised as key to securing UHC through the 
efficient and equitable allocation of health care and resources (Chalkidou et al., 2013). 
Therefore, promoting patient and public perspectives on the technologies being used is 
essential to assess the overall societal impact of health technologies.  Integrating the patient 
perspective in public health research and HTA activities has the potential to improve the 
quality of healthcare services through meaningful contributions from and to the patient and 
public.  
PPI/E could be used in South Asia, considering, as Cook and colleagues (2019) describe, ‘the 
variations in research infrastructure, cultural differences, the power differential between 
researched and researcher and often, lower research budgets.’  Similarly, the growing use of 
technology in South Asia could be co-created locally to meet the literacy needs of users. 
Need for PPI/E 
One aspect of PPI/E is advising on and writing lay summaries; describing the research in 
language that ordinary people can understand and is relevant to their context. Involving 
people with local knowledge and experience of the area of research not only increases the 
potential outcome of the research but also achieve academic, economic and societal impact in 
the wider community (Hughes & Duffy, 2018). 
PPI can occur in specific or all phases of the research cycle, from prioritising research area, 
research design, assisting with recruitment of study participants, data collection and analysis, 
monitoring and evaluation to dissemination (Greenhalgh et al., 2019; Ball et al., 2019). 
Starting with developing the research proposal, PPI/E could start with preliminary 
discussions to identify research priorities.  During the research process: PPI/E could help 
assess the research instrument being used such as the appropriateness, wording, language and 
timing of research instruments (e.g. questionnaires, interview schedules) to the public. They 
can be consulted to see whether they understand or interpret the data/findings in the same 
way as research team.  At the dissemination stage people could help to develop patient 
information leaflets/websites or other research materials for awareness-raising of the research 
through various media.  
What and whom to ask  
In PPI/E as in any part of research and HTA you need to make sure you ask the right kind of 
questions for the right reasons and technology being tested.  In other words: “What are you 
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asking, and why are you asking it?” Also you need to consider which sub-group in the 
population represents your PPI best.  
Some see PPI/E as a burden, perhaps as another obstacle in research in a generally risk-averse 
society.  Others, more positive towards PPI/E, fear an element of tokenism, the rise of the so-
called professional patient.  Examples of that can be seen in the grant application process in 
the UK, where the same paid member of staff of a health charity appears as PPI/E 
representative on several competing grants.   
PPI/E in South Asia 
There has been limited application of PPI/E in the more traditional patriarchal countries of 
South Asia.  PPI is less patriarchal and more democratic, as it gives people a voice in shaping 
services, decision-making and research.  The latter can be a threat to highly trained 
researchers (as PPI was for some in Europe 25 years ago), who may fail to see the value of 
the ‘lay person’s’ voice or fear that involving patients may include, what may be deemed, 
irrelevant remark, only offers a few unrepresentative perspectives and threaten the scientific 
rigour of their research, which could make the research unfeasible (Turk et al., 2017). 
We have been researching health in South Asia, mainly Nepal and Bangladesh for 15 years, 
but we have only recently started make users part of the research process early on.  PPI/E is 
not common in the health research landscape in South Asia.  A recent systematic review on 
health research in LMICs considered involvement and impact (Cook et al., 2019) found 62 
studies and  PPI was mostly used  in the planning stage and collaborations  were the most 
common level of involvement. The review found little evidence of effectiveness and impact 
tended to relate to increased relevance to the community, empowerment of participants and 
alterations in study design.  Cook and colleagues’ (2019) overall conclusion was that proper 
PPI involvement in health research in LMICs is still rare.  
Nepal 
We are involving users to develop nursing Continuous Professional Development (CPD). 
Nurses provided the PPI/E part of the research proposal development.  PPI/E has helped us to 
understand the need of nurses however we still feel we have failed to recognise the patient 
and public perspective.  We planned the recommendations with PPI/E input around 
dissemination events with nurse practitioners and policy makers in Kathmandu to achieve 
acceptance by national nursing/health policy-makers. We shared what works and what is 
feasible in CPD to enhance nurses’ knowledge and skills. The nurses valued their 
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involvement in dissemination event and reported it provided them with ownership in the CPD 
framework development. We now realised that involving patients could have given us insight 
in their perceptions of CPD training from the research proposal stage i.e. how it can benefit 
nurse-patient interactions, for example to  help nurses understanding patients’ perspectives in 
the CPD training.  The main idea of CPD is to offers the opportunity to maintain, improve 
and broaden knowledge, expertise and enhance nurses’ practice and improve nurse’s 
interpersonal relationships with multidisciplinary team, patients and family for better quality 
of care (RCN, 2016, Simkhada et al., 2016) 
Bangladesh 
A multi component hypertension control programme in Bangladesh driven by rural 
Community Health Workers (CHWs) in collaborations with government doctors has set an 
example of the value of PPE in strengthening primary health systems for delivery of 
hypertension (Jafar et al., 2017).  A group of researchers in Bangladesh, Pakistan, Sri Lanka 
and Singapore evaluated the impact of a multi component hypertension control program titled 
‘Control of Blood Pressure and Risk Attenuation in Bangladesh, Pakistan, and Sri Lanka 
(COBRA-BPS)  (Jafar et al., 2020). The CHWs were trained to use a digital blood pressure 
monitor (Omron: HEM-7300) to measure blood pressure of the hypertensive study 
participants during routine home .  The CHWs also conducted home-based health education 
with these patients and their family to modify  lifestyle as well as promote medication 
adherence. The CHWs in Bangladesh detected patients with uncontrolled blood pressure and 
mobilized the family to refer thems to government primary health facilities for management 
of uncontrolled blood pressure by trained doctors.  A significance reduction of blood pressure 
was observed among the patients in the intervention areas compared to those in the usual care 
after two years (2016-2018).  
The proactive engagement of the CHWs with the patients in the community and primary-care 
doctors created a high demand for hypertension care and subsequently anti-hypertensive 
medicines were made available at the primary health facilities throughout the country. PPI/E 
was a key part of the COBRA-BPS programme’s implementation , and has demonstrated the 
value of involving PPI/E in improving the quality of care as well as acceptability of health 




Developing PPI/E in a culturally appropriate way  
In South Asia health workers are often seen as expert in patients’ conditions. It is important 
for researcher to understand this context.  Therefore it is important to consider practical 
questions when planning for PPI/E i.e. how do we change this culture? How do we empower 
patients to see that they have a very unique expertise of their own building rapport and 
creating opportunities for collaboration takes time (and should be factored/costed into any 
bids). How and where do we create an environment where people feel safe and it is familiar 
to them? Are there barriers to break through where only ‘community leaders’ are consulted?  
One key way to involve people is to ‘go to where they are,’ but will there be issues of trust – 
unless of course, there is someone from that culture/community as part of the research team 
or the people themselves are trained as researchers.) 
Cultural influences, politics, and economic status can play a big role in South Asia, and as 
such would affect PPI/E in public health and HTA research. There is increasing interest in 
human-centric design in the public health and HTA research to test locally the new 
technology adopted from HICs. In Nepal and Bangladesh health workers are known as the 
experts; they know ‘everything’ about the patient’s condition and the patient follow what is 
being said; having little/no voice in their own health care planning. Therefore it is important 
to explore how PPI/E could effectively work in a South Asian context and ascertain whether 
people value being involved in research design, processes and dissemination.  
Challenges of PPI/E may be avoided through clear planning of the PPI/E activity in the early-
planning stages of the proposed study (Brett et al., 2012) and more importantly there is need 
for awareness on importance of the patient involvement in the research in South Asia. 
Researcher also need to understand the users feeling of empowered, valued, listened to and 
generally more positive about their experiences when they engages in the research process 
(Brett et al., 2014).  When researchers planned PPI/E it is important to communicate in a 
culturally appropriate way, educate the public that their views are important and useful in the 
service provision. However, creating a mechanism for accountability of the health care 
providers to patients and public would remain a challenge as well as an essential element for 
promoting PPI/E in South Asian settings. The patients and the public can provide valuable 
input; offering a unique perspective in the project. 
In Nepal and Bangladesh, there is lay involvement in the process of dissemination, often with 
stakeholders (service providers) however there is some notion of community engagement in 
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health education/promotion programmes. There may be a highly educated representative of 
the community acting as the voice of the people, for example inclusion of different ethnicity, 
rural and urban and gender.   
It is important to have representative and diverse people in the group to avoid the over-
emphasizing of particular problems; groups being dominated by strong characters and their 
perspectives; groups being overshadowed by personal experience stories. Representation of 
the population is not only the element of the PPI, it is important they have some kind of 
decision making around research process. They should have key role on dissemination of 
research findings, as they are able to provide access to a wider audience than traditional 
academic circles. We believe PPI/E can improve the quality of research projects, particular 
developing health interventions and strengthen their relevance and increasing the likelihood 
of achieving impact.   The global pandemic COVID-19 also adds the value of PPI/E in 
designing research grants or surveys in in South Asia.  
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